Clinical response to interferon beta and glatiramer acetate in MS patients http://www.ncbi.nlm.nih.gov/pubmed/23060103
"Conclusions: Our sample of Brazilian patients with MS has similarities when compared to other studies and there was no statistically significant difference regarding age, gender, ethnicity or disease duration between responders and nonresponders."